Literature DB >> 11805505

Ocular surface changes in pterygium.

Cordelia M L Chan1, Yan Ping Liu, Donald T H Tan.   

Abstract

PURPOSE: To evaluate ocular surface abnormalities in eyes with pterygium.
METHODS: Impression cytology was performed on 56 pterygia in 50 eyes with primary or recurrent pterygium. Superior, inferior, nasal, and temporal bulbar conjunctivae were evaluated.
RESULTS: The ocular surface morphology directly over the pterygium was found to be abnormal in 100% of cases. This was significant compared with abnormalities in 2.4% in the superior bulbar conjunctiva, 54.5% in the inferior bulbar conjunctiva, and 58.1% in the clinically unaffected interpalpebral conjunctiva. The epithelial cells in pterygium demonstrated squamous metaplasia in 73.2% of cases, with marked enlargement and elongation of the cells and pyknotic changes in the nuclei. Squamous metaplasia was also seen in the inferior conjunctiva (31.7%) and the clinically unaffected interpalpebral conjunctiva (54.8%) but without the advanced changes seen over the pterygium (p < 0.001). A low cellular yield was obtained over the pterygium in 98.2% of cases but only 22.7% in the inferior conjunctiva and 22.6% in the clinically unaffected interpalpebral conjunctiva (p < 0.001). Mucinous hyperplasia signifying increased goblet cell density was observed over the surface of the pterygium in 87.5% compared with 2.4% in the superior conjunctiva, 15.9% in the inferior conjunctiva, and 12.9% in the clinically unaffected interpalpebral conjunctiva (p < 0.001).
CONCLUSION: The cytology of surface cells in pterygium exhibits squamous metaplasia with increased goblet cell density. A graded series of ocular surface changes exists throughout the bulbar conjunctiva in eyes with pterygium, with the most advanced changes occurring directly over the pterygium surface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805505     DOI: 10.1097/00003226-200201000-00009

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  19 in total

1.  Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium.

Authors:  Satoru Kase; Shuji Takahashi; Izuru Sato; Katsuya Nakanishi; Kazuhiko Yoshida; Shigeaki Ohno
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

2.  Exfoliating goblet cell hyperplasia mimicking pterygium: a clinicopathological case report.

Authors:  Anne E Barañano; Daniel V Vasconcelos-Santos; Narsing A Rao
Journal:  Int Ophthalmol       Date:  2010-01-03       Impact factor: 2.031

3.  Limbal epithelial stem-microenvironmental alteration leads to pterygium development.

Authors:  Prosun Das; Arjun Gokani; Ketaki Bagchi; Gautam Bhaduri; Samaresh Chaudhuri; Sujata Law
Journal:  Mol Cell Biochem       Date:  2015-01-06       Impact factor: 3.396

4.  Conjunctival-Limbal Autograft for Primary and Recurrent Pterygium.

Authors:  K N Jha
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.

Authors:  Hamid Gharaee; Mohammad Reza Shayegan; Mohammad Reza Khakzad; Sina Kianoush; A-Reza Varasteh; Mojtaba Sankian; Mojtaba Meshkat
Journal:  Int Ophthalmol       Date:  2014-10-26       Impact factor: 2.031

6.  Immunolocalisation of E-cadherin and beta-catenin in human pterygium.

Authors:  Satoru Kase; Mitsuhiko Osaki; Izuru Sato; Shuji Takahashi; Katsuya Nakanishi; Kazuhiko Yoshida; Hisao Ito; Shigeaki Ohno
Journal:  Br J Ophthalmol       Date:  2007-03-14       Impact factor: 4.638

Review 7.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

8.  Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell proliferation of pterygium fibroblasts.

Authors:  Ying Su; Feng Wang; Hu Qi; Shi Guang Zhao; Xue Li; Hao Cui
Journal:  Mol Vis       Date:  2011-01-22       Impact factor: 2.367

9.  The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery.

Authors:  Ece Turan-Vural; Banu Torun-Acar; S Argun Kivanc; Suphi Acar
Journal:  Clin Ophthalmol       Date:  2011-06-29

10.  Study of the expression of CD30 in pterygia compared to healthy conjunctivas.

Authors:  Yonathan Garfias; Víctor Manuel Bautista-De Lucio; Cynthia García; Angel Nava; Leonardo Villalvazo; María Carmen Jiménez-Martínez
Journal:  Mol Vis       Date:  2009-10-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.